Blog

Julie Gralow: A terrific Women and Allies in RCC session at IKCSNA24

citycancerchallenge.org

Nov 10, 2024, 16:07

Julie Gralow: A terrific Women and Allies in RCC session at IKCSNA24

Julie Gralow, Chief Medical Officer of ASCO, shared a post on X:

“Fun to participate in a terrific Women and Allies in RCC session at IKCSNA24.”

Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, shared this post, adding:

“Very grateful to you Julie Gralow for coming all the way to Louisville to support Kidney Cancer, Women in RCC session at IKCSNA24! Keeping doors open for those who come behind — your advice is well taken.”

More posts featuring Julie Gralow and Tian Zhang.

Julie Gralow is the Chief Medical Officer (CMO) of the American Society of Clinical Oncology (ASCO). She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN).

Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance.

Tian Zhang is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in the diagnosis and treatment of genitourinary malignancies. She has gained an international reputation developing clinical trials in kidney, prostate, and bladder cancers.

She serves as the study chair for PDIGREE, a phase III trial in metastatic renal cell carcinoma. She serves on numerous committees, including as Co-chair of the National Cancer Institute Genitourinary (GU) Steering Committee Renal Task Force and as Chair of the Chinese American Hematologist and Oncologist Network (CAHON) Academic Committee.

She is a member of several ASCO clinical management guidelines committees as well as the Alliance for Clinical Trials in Oncology, GU Oncology, and Immuno-Oncology Committees. She has received multiple peer-reviewed grants, a Resident Research Mentoring Award from Duke, and, notably, the 2021 Cancer Prevention and Research Institute of Texas (CPRIT) Scholar Rising Stars Award.